[Perioperative management of patients with cardiomyopathies: preface and comments]

Eiichi Inada1

  • 1Department of Anesthesiology and Pain Medicine, University of Juntendo Medical School, Tokyo 113-8421.

Masui. the Japanese Journal of Anesthesiology
|February 25, 2014
PubMed

Insights

Cardiomyopathies are myocardial diseases causing heart failure and sudden death. Perioperative management requires individualized strategies for low cardiac output, arrhythmias, and anticoagulation.

Area of Science:

  • Cardiology
  • Myocardial Diseases

Context:

  • Cardiomyopathies represent a diverse group of myocardial diseases.
  • These conditions lead to myocardial dysfunction, causing heart failure via systolic and/or diastolic dysfunction.

Purpose:

  • To outline the complexities in managing patients with cardiomyopathies, particularly during the perioperative period.
  • To highlight the need for tailored management strategies based on specific pathophysiological characteristics.

Summary:

  • Cardiomyopathies often have a poor prognosis due to progressive heart failure and risk of sudden cardiac death from arrhythmias.
  • Effective perioperative management focuses on addressing low cardiac output, managing serious arrhythmias, and considering anticoagulation for conditions like atrial fibrillation.
  • Evaluation and management of cardiac implantable electronic devices, such as pacemakers and implantable cardioverter-defibrillators, are crucial.

Impact:

  • This information is vital for clinicians to optimize perioperative care for cardiomyopathy patients.
  • Improved management can potentially reduce adverse outcomes, including heart failure progression and sudden cardiac death.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K